U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012

NEW YORK, July 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0851584/US-Market-for-Diabetes-Monitoring-Treatment-and-Drug-Delivery-2012.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The U.S. market for diabetes diagnosis, treatment and drug delivery is expected to exceed $17.87 billion by 2018.

• continuous glucose monitoring systems,

• blood glucose test strips,

• lancets and lancing devices,

• insulin,

• insulin syringes,

• insulin pens and

• insulin pumps

Market growth is expected to be fueled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

Market growth for diabetes diagnosis, treatment and drug delivery will be led by double-digit growth in the continuous glucose monitor, insulin pen and insulin pump segments.

Within the diabetes diagnosis, treatment and drug deliver market, companies such as Novo Nordisk, Sanofi, Eli Lilly and Lifescan lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. This is an exective summary only, the full report is also available for purchase.TABLE OF CONTENTS...ILIST OF FIGURES.VILIST OF CHARTSXEXECUTIVE SUMMARY... 11.1 U.S. DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET.. 11.2 GROWTH TRENDS BY SEGMENT ... 21.3 BLOOD GLUCOSE MONITORING MARKET 31.4 INSULIN MARKET.. 41.5 INSULIN SYRINGE MARKET .. 51.6 INSULIN PEN MARKET .. 61.7 INSULIN PUMP MARKET ... 71.8 COMPETITIVE ANALYSIS .. 8RESEARCH METHODOLOGY. 92.1 RESEARCH SCOPE . 92.2 IDATA'S 9-STEP METHODOLOGY . 9Step 1: Project Initiation & Team Selection .. 10Step 2: Prepare Data Systems and Perform Secondary Research. 12Step 3: Preparation for Interviews & Questionnaire Design 13Step 4: Performing Primary Research... 14Step 5: Research Analysis: Establishing Baseline Estimates 16Step 6: Market Forecast and Analysis ... 17Step 7: Identify Strategic Opportunities 19Step 8: Final Review and Market Release . 20Step 9: Customer Feedback and Market Monitoring. 21U.S. DIABETES DIAGNOSIS, TREATEMENT AND DRUG DELIVERYMARKET 223.1 INTRODUCTION ... 223.1.1 Types of Diabetes.. 223.1.1.1 Type 1 Diabetes ...223.1.1.2 Type 2 Diabetes ...223.1.1.3 Gestational Diabetes ...233.1.1.4 Prediabetes ..233.1.2 Diabetes Complications 243.1.3 Risk Factors Associated with Type I and Type 2 Diabetes ... 263.1.4 Signs and Symptoms.. 283.1.5 Diabetes Monitoring . 293.1.5.1 Initial Diagnosis ..293.1.5.2 Blood Glucose Monitoring Systems.303.1.5.3 Urinary Glucose Monitoring ...303.1.5.4 Noninvasive and Minimally Invasive Monitoring Devices ..313.1.6 Treatment.. 323.1.6.1 Lifestyle Measures ...323.1.6.2 Insulin ..323.1.6.3 Oral Antidiabetic Drugs ..323.1.6.4 Injectable Antidiabetic Drugs..333.1.7 Drug Delivery Systems.. 333.1.7.1 Insulin Syringes ...333.1.7.2 Insulin Pens .333.1.7.3 Insulin Pumps ..333.1.7.4 Inhaled Insulin.343.2MARKET OVERVIEW... 353.3 TREND ANALYSIS BY MARKET SEGMENT.. 403.4MARKET DRIVERS AND LIMITERS .. 433.4.1 Market Drivers.. 433.4.2 Market Limiters. 443.5 COMPETITIVE ANALYSIS 463.5.1 Market Concentration... 553.6MERGERS AND ACQUISITIONS 57TRADITIONAL BLOOD GLUCOSE METER MARKET 584.1 INTRODUCTION ... 584.2MARKET OVERVIEW... 604.3MARKET ANALYSIS AND FORECAST .. 654.3.1 Professional Blood Glucose Meter Market... 674.3.2 Personal Blood Glucose Meter Market 734.4MARKET DRIVERS AND LIMITERS .. 764.4.1 Market Drivers.. 764.4.2 Market Limiters. 774.5 COMPETITIVE ANALYSIS 79CONTINUOUS GLUCOSE MONITORING MARKET 845.1 INTRODUCTION ... 845.2MARKET OVERVIEW... 865.2.1 Total Continuous Glucose Monitoring Market. 865.2.2 Emerging Markets: Intravascular Continuous Glucose Monitoring 865.3MARKET ANALYSIS AND FORECAST .. 915.3.1 Total CGM Market 915.4MARKET DRIVERS AND LIMITERS .. 985.4.1 Market Drivers.. 985.4.2 Market Limiters. 995.5 COMPETITIVE ANALYSIS .. 101BLOOD GLUCOSE TEST STRIP MARKET ... 1046.1 INTRODUCTION . 1046.2MARKET OVERVIEW. 1056.3MARKET ANALYSIS AND FORECAST 1106.3.1 Professional Blood Glucose Test Strip Market... 1136.3.2 Personal Blood Glucose Test Strip Market 1166.4MARKET DRIVERS AND LIMITERS 1196.4.1 Market Drivers 1196.4.2 Market Limiters... 1206.5 COMPETITIVE ANALYSIS .. 121LANCET AND LANCING DEVICE MARKET 1267.1 INTRODUCTION . 1267.2MARKET OVERVIEW. 1277.3MARKET ANALYSIS AND FORECAST 1327.3.1 Professional Lancet and Lancing Device Market... 1357.3.2 Personal Lancet and Lancing Device Market 1387.4MARKET DRIVERS AND LIMITERS 1417.4.1 Market Drivers 1417.4.2 Market Limiters... 1427.5 COMPETITIVE ANALYSIS .. 143INSULIN MARKET.. 1478.1 INTRODUCTION . 1478.1.1 Insulin Types... 1478.2MARKET OVERVIEW. 1518.3MARKET ANALYSIS AND FORECAST 1568.4MARKET DRIVERS AND LIMITERS 1668.4.1 Market Drivers 1668.4.2 Market Limiters... 1678.5 COMPETITIVE ANALYSIS .. 168INSULIN SYRINGE MARKET .. 1719.1 INTRODUCTION . 1719.2MARKET OVERVIEW. 1729.3MARKET ANALYSIS AND FORECAST 1769.3.1 Professional Insulin Syringe Market .. 1799.3.2 Personal Insulin Syringe Market 1829.4MARKET DRIVERS AND LIMITERS 1859.4.1 Market Drivers 1859.4.2 Market Limiters... 1869.5 COMPETITIVE ANALYSIS .. 187INSULIN PEN MARKET. 19010.1 INTRODUCTION ... 19010.2MARKET ANALYSIS AND FORECAST .. 19110.3MARKET DRIVERS AND LIMITERS .. 19410.3.1 Market Drivers.. 19410.3.2 Market Limiters. 19510.4 COMPETITIVE ANALYSIS 196INSULIN PUMP MARKET. 19911.1 INTRODUCTION ... 19911.2MARKET OVERVIEW... 20111.3MARKET ANALYSIS AND FORECAST .. 20611.3.1 Total Traditional Insulin Pump Market 20811.3.1.1 Traditional Pump Market 21011.3.1.2 Infusion Set Market..21311.3.2 Total Patch Pump Market. 21511.3.2.1 Patch Pump Controller Market ...21711.3.2.2 Insulin Pod Market ..22011.3.3 Simple Pump Market. 22311.4MARKET DRIVERS AND LIMITERS .. 22611.4.1 Market Drivers.. 22611.4.2 Market Limiters. 22711.5 COMPETITIVE ANALYSIS 22911.5.1.1 Emerging Competitors.231APPENDIX 1: EMERGING MARKETS & ALTERNATIVE THERAPIES. 23412.1 ARTIFICIAL PANCREAS ... 23412.1.1 Mechanical Artificial Pancreas 23412.1.2 Bio-Artificial Pancreas . 23512.2 NEEDLESS INJECTORS . 236ABBREVIATIONS 238

More  

Check our  

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker